Dipal Doshi insider trades

Open-market stock purchases and sales by Dipal Doshi, CEO at Entrada Therapeutics, Inc, from SEC Form 4 filings since Jul 7, 2014.

Recent trades

DateStockTradeValue
Sep 2, 2026TRDA Entrada Therapeutics, IncSold (not open market)$62.3K
Mar 3, 2026TRDA Entrada Therapeutics, IncSold (not open market)$225K
Mar 2, 2026TRDA Entrada Therapeutics, IncSold (not open market)$115K
Mar 1, 2026TRDA Entrada Therapeutics, IncBought (not open market)—
Mar 1, 2026TRDA Entrada Therapeutics, IncBought (not open market)—
Feb 5, 2026AZTA Azenta, IncBought (not open market)$158K

Companies traded

  • TRDA Entrada Therapeutics, Inc: 49 sales, last Sep 2, 2026
  • AZTA Azenta, Inc: other filings, last Feb 5, 2026
  • FOLD Amicus Therapeutics Inc: 1 sale, last Jul 8, 2015

Get free alerts when Dipal Doshi files a new trade →